10.3 Vascular Closure Devices
Key Takeaways
- Vascular closure devices (VCDs) achieve hemostasis after arterial access, supplementing or replacing manual compression
- Femoral VCD categories include suture-mediated, collagen plug with anchor, clip-based, and sealant-assisted systems—each with distinct deployment steps
- Radial closure typically uses patent hemostasis with a compression band or TR band rather than intravascular plugs
- Device selection depends on sheath size, access location (common femoral artery vs radial), anticoagulation, and anatomy
- RCIS monitors for closure complications: hematoma, pseudoaneurysm, arteriovenous fistula, retroperitoneal bleeding, infection, and limb ischemia
10.3 Vascular Closure Devices
Quick Answer: After PCI, hemostasis at the arterial access site protects patients from bleeding and enables safe ambulation. Vascular closure devices (VCDs) mechanically or chemically seal the arteriotomy, often shortening time to hemostasis versus manual compression alone—especially after large-bore femoral sheaths. RCIS prepares devices, assists deployment, enforces post-closure bedrest and monitoring, and recognizes complications such as pseudoaneurysm and retroperitoneal hemorrhage.
Why Closure Matters in PCI
Modern PCI uses systemic anticoagulation (heparin, bivalirudin) and antiplatelet agents. When the sheath is removed, the common femoral artery (CFA) or radial artery puncture must seal completely. Inadequate hemostasis causes:
- Access site hematoma
- Pseudoaneurysm (contained extravasation pulsating outside the wall)
- Arteriovenous fistula (communication with adjacent vein)
- Retroperitoneal hemorrhage (especially high femoral punctures)
- Infection at closure site
- Limb ischemia (rare with aggressive closure or embolized material)
RCIS participates in sheath removal timing (ACT thresholds per protocol), device selection, and first-hour assessments that catch complications before hemodynamic collapse.
Manual Compression Versus VCD
Manual compression (or assisted compression with a C-clamp or FemoStop) remains the universal fallback. Typical femoral manual compression requires 10–20+ minutes of firm pressure at the arteriotomy, then a pressure dressing and hours of bedrest depending on sheath size and anticoagulation.
Vascular closure devices aim to:
- Shorten time to hemostasis and ambulation (protocol-dependent)
- Improve patient comfort in high-risk bleeding patients (selected cases)
- Facilitate large-bore access closure (structural heart, Impella, some PCI sheaths)
Not every patient qualifies—anatomy, infection, severe PAD, and uncontrolled hypertension may contraindicate specific devices per IFU.
Femoral Closure Device Categories
Most RCIS exams emphasize common femoral arterial access because closure devices are most varied there. Know mechanism, not just trade names.
Suture-Mediated Closure
Example families: Perclose ProGlide, ProStyle.
A needle driver places sutures across the arteriotomy before or as the sheath is withdrawn; knots approximate the vessel wall. Often used for large-bore access because sutures can close bigger holes when deployed correctly.
RCIS tasks: prep device, assist suture deployment sequence, maintain wire access if protocol requires, and confirm bleeding control before transfer.
Collagen Plug With Intravascular Anchor
Example families: Angio-Seal (historically widely taught).
Deploys a footplate inside the artery and collagen plug outside the puncture tract; the tract thromboses around the anchor. Requires attention to anchor location—maldeployment causes limb ischemia or persistent bleeding.
Clip-Based / Nitinol Clip Systems
Example families: StarClose SE (clip-based historical platform).
Places a nitinol clip extravascularly to approximate the arteriotomy. Less common in some systems today but still appears in legacy exam content.
Sealant and Gel Assistants
Example families: Mynx family (sealant at arteriotomy tract), other hemorrhage control pads used adjunctively.
Some devices use proprietary sealant or chitosan to achieve hemostasis with less intravascular metal—useful when intravascular anchors are undesirable.
Active Compression Assist Devices
Example: FemoStop (not a permanent implant)—temporary balloon compression of the access site; RCIS must distinguish temporary assists from permanent closure implants.
Deployment Principles (Femoral)
Regardless of brand, RCIS should understand the shared workflow:
- Confirm ACT or protocol allows sheath pull.
- Identify puncture level fluoroscopically when possible—below inguinal ligament, above bifurcation reduces complications.
- Administer analgesia/sedation as ordered for removal.
- Deploy device per IFU while maintaining wire or sheath control as required.
- Observe for immediate bleeding, bruit/thrill, and distal pulse.
- Apply dressing and document device lot, type, and deployment success.
- Enforce bedrest, head-of-bed limits, and neurovascular checks per protocol.
Never discard the deployment log card—it contains lot numbers for recalls and medicolegal traceability.
Radial Access Closure
Transradial PCI (TRI) has grown dramatically because radial closure complications are generally lower than femoral, and early ambulation is easier.
Standard radial closure uses patent hemostasis:
- Remove sheath with counter-traction.
- Apply compression device (TR band, VascBand, etc.) over the radial artery.
- Gradually reduce pressure while maintaining ulnar collateral flow (pulse oximetry on thumb or plethysmography)—avoid radial artery occlusion (RAO).
RCIS monitors hand perfusion, paresthesia, and band deflation schedule. Intravascular femoral-style plugs are generally not used in routine radial closure.
Distal Radial Access
Some labs use snuffbox (distal radial) access; closure still relies on compression bands with modified positioning—know your lab's checklist.
Device Selection Factors
| Factor | Implication |
|---|---|
| Sheath size | Large bore may require suture-mediated or two ProGlide strategy |
| Anticoagulation status | Higher bleeding risk may delay pull or favor specific devices |
| Puncture location | High punctures increase retroperitoneal bleed risk—may avoid certain plugs |
| Peripheral artery disease | Distal pulses already weak—monitor closely after closure |
| Previous closure failure | Alternate device or manual compression |
| Infection at site | Many IFUs contraindicate implantable collagen devices |
Physicians select devices; RCIS ensures correct inventory, ** sterility**, and IFU steps.
Post-Closure Monitoring
First 15–60 Minutes
- Vital signs and access checks per protocol (often q15 min initially)
- Inspect dressing for expanding hematoma
- Palpate for bruit/thrill (pseudoaneurysm/AVF)
- Confirm distal pulses, capillary refill, and foot/hand warmth
After Transfer to Holding/Unit
- Teach patient to report back pain (retroperitoneal bleed), dyspnea, or rapid heart rate
- Maintain bedrest duration and lifting restrictions per sheath size/device
- DAPT continues regardless of closure type—bleeding risk remains
Ultrasound Follow-Up
If pseudoaneurysm suspected (pain, bruit, expanding mass), bedside ultrasound or vascular surgery consult follows. Ultrasound-guided compression or thrombin injection may be ordered—outside RCIS scope but part of complication recognition.
Complications Table for RCIS Recognition
| Complication | Clues | Initial response |
|---|---|---|
| Hematoma | Pain, firm swelling, drop in Hgb | Pressure, labs, imaging if large |
| Pseudoaneurysm | Pulsatile mass, bruit | Ultrasound, vascular consult |
| AVF | Continuous bruit, thrill | Often small; may need intervention if large |
| Retroperitoneal bleed | Back/flank pain, hypotension, hematocrit fall | Large-bore IV, transfuse, CT angiography, IR/surgery |
| Infection | Erythema, drainage days later | Cultures, antibiotics per protocol |
| RAO (radial) | Hand pain, loss of radial pulse post band | Prevention via patent hemostasis; ultrasound if symptomatic |
Manual Compression Fallback
Every closure device case must be able to revert to manual compression if deployment fails. RCIS keeps FemoStop, sandbags, and staff trained in compression technique immediately available.
Documentation and Quality Metrics
Document access site, sheath size, closure method, device serial/lot, time to hemostasis, and complications. Registries track VCD failure rates and bleeding events—accurate charting supports quality improvement.
Official Resources
- Manufacturer IFUs for Perclose, Angio-Seal, Mynx, and institutional preferred devices
- SCAI transradial toolkit — radial hemostasis and RAO prevention
- CCI RCIS matrix — post-procedure hemostasis tasks
Closure is the last PCI act you control before the patient leaves the lab. Knowing device categories, radial patent hemostasis, monitoring intervals, and complication signatures completes the RCIS interventional loop—from wiring and stenting to a safe, dry access site.
Which vascular closure mechanism uses sutures placed across the arteriotomy to approximate the vessel wall?
What is the primary goal of patent hemostasis during transradial closure?
A post-PCI patient develops hypotension, flank pain, and dropping hemoglobin with a high femoral stick. Which complication should the team suspect first?